(Q31156150)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

0 references

1 reference

angiogenesis inhibitor

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Afanasieva TA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Wittmer M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Vitaliti A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Ajmo M

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Klemenz R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

1850-1859

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

The vascular endothelial growth factor family of polypeptides

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

VEGF: an update on biological and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Making antibodies by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Progress in antiangiogenic gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Targeting tumor angiogenesis with gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Excessive tumor-elaborated VEGF and its neutralization define a lethal paraneoplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

FcRn: the MHC class I-related receptor that is more than an IgG transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Hierarchical affinity maturation of a phage library derived antibody for the selective removal of cytomegalovirus from plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

In vivo phage display and vascular heterogeneity: implications for targeted medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

inferred from DOI database lookup

7 January 2021

based on heuristic

In vivo tumor targeting of a recombinant single-chain antigen-binding protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302085

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302085

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12960975%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 November 2019

1009047210

0 references

1 reference